{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:52:15Z","timestamp":1795024335288,"version":"4.10.2"},"reference-count":62,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education and Science","award":["statutory NIO-PIB"],"award-info":[{"award-number":["statutory NIO-PIB"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Malignant adnexal cancers of the skin\u2014extremely rare neoplasms\u2014are mostly reported as non-symptomatic, slow-growing nodules. These carcinomas occur mainly in the middle-aged (50\u201360 years of age); they are mostly localized on the upper part of the body and are locally aggressive, infiltrate surrounding tissue, and metastasize to regional lymph nodes. The patients\u2019 outcomes depend on multiple prognostic factors, including the size of the primary tumor and its mitotic count. Surgical resection of the primary tumor with or without regional lymph nodes is the treatment method of choice; however, due to aggressive tumor behavior, perioperative treatment may be considered. The role and efficacy of radiotherapy in the treatment of skin adnexal malignancies are not yet fully defined. Some authors suggest that adjuvant radiotherapy may be considered in locally advanced and regional disease. The aim of this study was to evaluate treatment outcomes and assess the efficacy of combined therapy in patients with adnexal malignancies. Our analysis covered all cases of cutaneous adnexal tumor patients diagnosed and provided with multidisciplinary treatment with surgery and radiotherapy since the beginning of 2009.<\/jats:p>","DOI":"10.3390\/cancers14040998","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T20:26:41Z","timestamp":1645043201000},"page":"998","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Treatment of Malignant Adnexal Tumors of the Skin: A 12-Year Perspective"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1562-8450","authenticated-orcid":false,"given":"Marcin","family":"Kleibert","sequence":"first","affiliation":[{"name":"Department of Soft Tissue\/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research, Institute of Oncology, 02-781 Warsaw, Poland"},{"name":"Faculty of Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0830-2711","authenticated-orcid":false,"given":"Iga","family":"P\u0142achta","sequence":"additional","affiliation":[{"name":"Department of Soft Tissue\/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research, Institute of Oncology, 02-781 Warsaw, Poland"},{"name":"Faculty of Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2107-3810","authenticated-orcid":false,"given":"Anna M.","family":"Czarnecka","sequence":"additional","affiliation":[{"name":"Department of Soft Tissue\/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research, Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3960-7673","authenticated-orcid":false,"given":"Mateusz J.","family":"Spa\u0142ek","sequence":"additional","affiliation":[{"name":"Department of Soft Tissue\/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research, Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5028-3422","authenticated-orcid":false,"given":"Anna","family":"Szumera-Cie\u0107kiewicz","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"},{"name":"Department of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, 00-791 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8920-5429","authenticated-orcid":false,"given":"Piotr","family":"Rutkowski","sequence":"additional","affiliation":[{"name":"Department of Soft Tissue\/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research, Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/jso.23331","article-title":"Increasing incidence and survival of a rare skin cancer in the Netherlands. A population-based study of 2220 cases of skin adnexal carcinoma","volume":"107","author":"Stam","year":"2013","journal-title":"J. Surg. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.ejca.2011.10.004","article-title":"Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe","volume":"48","author":"Mallone","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_3","first-page":"1","article-title":"Italian cancer figures\u2014Report 2015: The burden of rare cancers in Italy","volume":"40","author":"Busco","year":"2016","journal-title":"Epidemiol. Prev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"P\u0142achta, I., Kleibert, M., Czarnecka, A.M., Spa\u0142ek, M., Szumera-Cie\u0107kiewicz, A., and Rutkowski, P. (2021). Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Follicular Differentiation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094759"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"P\u0142achta, I., Kleibert, M., Czarnecka, A.M., Spa\u0142ek, M., Szumera-Cie\u0107kiewicz, A., and Rutkowski, P. (2021). Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22105077"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s10147-013-0594-x","article-title":"Treatment strategy for cutaneous apocrine carcinoma","volume":"19","author":"Ogata","year":"2014","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ha, J.H., Lee, C., Lee, K.S., Pak, C.-s., Sun, C.-H., Koh, Y., and Chang, H. (2020). The molecular pathogenesis of Trichilemmal carcinoma. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-07009-7"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1067\/mjd.2001.105474","article-title":"Pilomatrix carcinoma: A report of a case arising from a previously excised pilomatrixoma and a review of the literature","volume":"44","author":"Sassmannshausen","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/ijd.12448","article-title":"Poroma: A review of eccrine, apocrine, and malignant forms","volume":"53","author":"Sawaya","year":"2014","journal-title":"Int. J. Dermatol."},{"key":"ref_10","first-page":"5263","article-title":"Chemotherapy of rare skin adnexal tumors: A review of literature","volume":"34","author":"Amoroso","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/cup.13046","article-title":"Pilomatrix carcinoma: 12-year experience and review of the literature","volume":"45","author":"Jones","year":"2018","journal-title":"J. Cutan. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e699","DOI":"10.1016\/S1470-2045(19)30673-4","article-title":"Sebaceous carcinoma: Evidence-based clinical practice guidelines","volume":"20","author":"Owen","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0190-9622(97)80295-2","article-title":"Trichilemmomal carcinoma in a patient with Cowden\u2019s disease (multiple hamartoma syndrome)","volume":"36","author":"Cooper","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_14","first-page":"711","article-title":"Management of trichilemmal carcinoma: An update and comprehensive review of the literature","volume":"40","author":"Hamman","year":"2014","journal-title":"Dermatol. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.12788\/cutis.0393","article-title":"Early Pilomatrix Carcinoma: A Case Report With Emphasis on Molecular Pathology and Review of the Literature","volume":"108","author":"Kamil","year":"2021","journal-title":"Cutis"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/0974-2077.79196","article-title":"Malignant proliferating trichilemmal tumour presenting early in life: An uncommon feature","volume":"4","author":"Rao","year":"2011","journal-title":"J. Cutan. Aesthetic Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1016\/j.transproceed.2014.09.064","article-title":"Sebaceous carcinoma in patients receiving long-term immunosuppresive treatment: Case report and literature review","volume":"46","author":"Krys","year":"2014","journal-title":"Transplant. Proc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2559.2009.03454.x","article-title":"Sebaceous neoplasia and the Muir-Torre syndrome: Important connections with clinical implications","volume":"56","author":"Shalin","year":"2010","journal-title":"Histopathology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"pkaa020","DOI":"10.1093\/jncics\/pkaa020","article-title":"Ambient Ultraviolet Radiation and Sebaceous Carcinoma Incidence in the United States, 2000\u20132016","volume":"4","author":"Sargen","year":"2020","journal-title":"JNCI Cancer Spectr."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kaplan, M.A., Arslan, D., Tatl\u0131, A.M., and Uysal, M. (2013). Eccrine porocarcinoma: A case report and literature review. J. Clin. Exp. Investig., 4.","DOI":"10.5799\/ahinjs.01.2013.03.0305"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jdcr.2015.02.002","article-title":"Primary cutaneous mucinous carcinoma of the eyelid treated with Mohs surgery","volume":"1","author":"Chavez","year":"2015","journal-title":"JAAD Case Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archdermatol.2010.105","article-title":"Cutaneous appendageal carcinoma incidence and survival patterns in the United States: A population-based study","volume":"146","author":"Blake","year":"2010","journal-title":"Arch. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/00000478-200106000-00002","article-title":"Eccrine porocarcinoma (malignant eccrine poroma): A clinicopathologic study of 69 cases","volume":"25","author":"Robson","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/1097-0142(19900415)65:8<1737::AID-CNCR2820650813>3.0.CO;2-Q","article-title":"The role of radiotherapy in the treatment of malignant sweat gland neoplasms","volume":"65","author":"Harari","year":"1990","journal-title":"Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.15761\/GOD.1000188","article-title":"Treatment of primary cutaneous apocrine carcinoma of the scalp\u2014Case and review of the literature","volume":"3","author":"Brown","year":"2016","journal-title":"Glob. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00000421-199904000-00005","article-title":"Apocrine gland carcinoma of the axilla: Review of the literature and recommendations for treatment","volume":"22","author":"Chamberlain","year":"1999","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/1097-0142(19930415)71:8<2491::AID-CNCR2820710811>3.0.CO;2-I","article-title":"Pilomatrix carcinoma","volume":"71","author":"Sau","year":"1993","journal-title":"Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/1097-0142(19840715)54:2<370::AID-CNCR2820540233>3.0.CO;2-E","article-title":"Pilomatrix carcinoma with pulmonary metastasis. Report of a case","volume":"54","author":"Gould","year":"1984","journal-title":"Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13256-017-1212-8","article-title":"Retrospective study of rare cutaneous malignant adnexal tumors of the head and neck in a tertiary care cancer hospital: A case series","volume":"11","author":"Waqas","year":"2017","journal-title":"J. Med. Case Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41698-019-0077-2","article-title":"Genomic landscape of a metastatic malignant proliferating tricholemmal tumor and its response to PI3K inhibition","volume":"3","author":"Gallant","year":"2019","journal-title":"NPJ Precis. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1309\/0XLEGFQ64XYJU4G6","article-title":"Proliferating Pilar Tumors","volume":"122","author":"Ye","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4103\/0973-1482.39001","article-title":"Malignant pilar tumor of the scalp: A case report and review of literature","volume":"3","author":"Siddha","year":"2007","journal-title":"J. Cancer Res. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3892\/mco.2013.74","article-title":"Survival study and clinicopathological evaluation of trichilemmal carcinoma","volume":"1","author":"Zhuang","year":"2013","journal-title":"Mol. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3892\/ol.2013.1726","article-title":"Tricholemmal carcinoma of the head and neck region: A report of 15 cases","volume":"7","author":"Feng","year":"2014","journal-title":"Oncol. Lett."},{"key":"ref_35","first-page":"57","article-title":"Adjuvant radiotherapy in management of trichilemmal carcinoma of left nasal alae with positive surgical margins: A case report","volume":"3","author":"Topkan","year":"2016","journal-title":"Case Rep. Clin. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.amsu.2017.06.027","article-title":"Porocarcinoma; presentation and management, a meta-analysis of 453 cases","volume":"20","author":"Salih","year":"2017","journal-title":"Ann. Med. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jamadermatol.2013.6006","article-title":"Primary cutaneous mucinous carcinoma: A systematic review and meta-analysis of outcomes after surgery","volume":"150","author":"Kamalpour","year":"2014","journal-title":"JAMA Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/hed.26178","article-title":"Eccrine porocarcinoma of the head and neck: Meta-analysis of 120 cases","volume":"42","author":"Le","year":"2020","journal-title":"Head Neck"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fmolb.2018.00076","article-title":"Molecular Diagnostics in Clinical Oncology","volume":"5","author":"Sokolenko","year":"2018","journal-title":"Front. Mol. Biosci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12105-016-0705-x","article-title":"Brooke-Spiegler Syndrome and Phenotypic Variants: An Update","volume":"10","author":"Kazakov","year":"2016","journal-title":"Head Neck Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/jnci\/djt277","article-title":"Cowden syndrome and the PTEN hamartoma tumor syndrome: Systematic review and revised diagnostic criteria","volume":"105","author":"Pilarski","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jaad.2015.09.074","article-title":"Muir-Torre syndrome (MTS): An update and approach to diagnosis and management","volume":"74","author":"John","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/gim.2014.19","article-title":"A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome","volume":"16","author":"Roberts","year":"2014","journal-title":"Genet. Med."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Denisova, E., Westphal, D., Surowy, H.M., Meier, F., Hutter, B., Reifenberger, J., Rutten, A., Schulz, A., Sergon, M., and Ziemer, M. (2021). Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies. Cancer Gene Ther.","DOI":"10.1038\/s41417-021-00347-z"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-0560.2009.01316.x","article-title":"Epidermal growth factor receptor (EGFR) expression in periocular and extraocular sebaceous carcinoma","volume":"37","author":"Ivan","year":"2010","journal-title":"J. Cutan. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.3747\/co.22.2467","article-title":"Unusual presentation of metastatic sebaceous carcinoma and its response to chemotherapy: Is genotyping a right answer for guiding chemotherapy in rare tumours?","volume":"22","author":"Kumar","year":"2015","journal-title":"Curr. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/path.4759","article-title":"Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma","volume":"240","author":"Tetzlaff","year":"2016","journal-title":"J. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40425-018-0357-3","article-title":"Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma","volume":"6","author":"Murugan","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1097\/IOP.0000000000001164","article-title":"Carboplatin and Pembrolizumab Chemoimmunotherapy Achieves Remission in Recurrent, Metastatic Sebaceous Carcinoma","volume":"34","author":"Kodali","year":"2018","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/IIO.0000000000000309","article-title":"The Role of Pembrolizumab in the Treatment of Sebaceous Carcinoma","volume":"60","author":"Lin","year":"2020","journal-title":"Int. Ophthalmol. Clin."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.12659\/AJCR.912552","article-title":"A Case Report of Recurrent Metastatic Sebaceous Carcinoma Which Showed Favorable Response Tt Non-Fluorouracil Based Chemotherapy","volume":"19","author":"Lee","year":"2018","journal-title":"Am. J. Case Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e228917","DOI":"10.1136\/bcr-2018-228917","article-title":"Metastatic porocarcinoma achieving complete radiological and clinical response with pembrolizumab","volume":"12","author":"Lee","year":"2019","journal-title":"BMJ Case Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0560.2006.00570.x","article-title":"Metastatic hidradenocarcinoma with demonstration of Her-2\/neu gene amplification by fluorescence in situ hybridization: Potential treatment implications","volume":"34","author":"Nash","year":"2007","journal-title":"J. Cutan. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"781","DOI":"10.5858\/134.5.781","article-title":"Hidradenocarcinomas: A brief review and future directions","volume":"134","author":"Gauerke","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2340\/00015555-1354","article-title":"Successful treatment of HER-2-positive metastatic apocrine carcinoma of the skin with lapatinib and capecitabine","volume":"92","author":"Hidaka","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1111\/ajd.13199","article-title":"A clinical, pathological and immunohistochemical series of 9 cases of primary cutaneous apocrine carcinomas of the head and neck","volume":"61","author":"Portelli","year":"2020","journal-title":"Australas. J. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/PAS.0b013e318209cac7","article-title":"Primary signet-ring cell\/histiocytoid carcinoma of the eyelid: A clinicopathologic study of 5 cases and review of the literature","volume":"35","author":"Requena","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/cup.12875","article-title":"Primary cutaneous histiocytoid carcinoma with distant metastasis","volume":"44","author":"Philips","year":"2017","journal-title":"J. Cutan. Pathol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1111\/1346-8138.13915","article-title":"Primary signet-ring cell\/histiocytoid carcinoma of the eyelid expressing androgen receptors and treated with bicalutamide","volume":"44","author":"Sakamoto","year":"2017","journal-title":"J. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1159\/000510097","article-title":"Cutaneous Adnexal Carcinoma with Apocrine Differentiation: A Challenging Diagnosis and Personalized Treatment with mTOR Inhibitor in a Very Rare Disease","volume":"13","author":"Libertini","year":"2020","journal-title":"Case Rep. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/bjd.13919","article-title":"Vismodegib induces significant clinical response in locally advanced trichoblastic carcinoma","volume":"173","author":"Lepesant","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1468-3083.2009.03301.x","article-title":"Sunitinib efficacy in the treatment of metastatic skin adnexal carcinomas: Report of two patients with hidradenocarcinoma and trichoblastic carcinoma","volume":"24","author":"Battistella","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/4\/998\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:21:04Z","timestamp":1760134864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/4\/998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":62,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["cancers14040998"],"URL":"https:\/\/doi.org\/10.3390\/cancers14040998","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,16]]}}}